INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of uniQure N.V. (QURE) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

Group 1 - A shareholder class action lawsuit has been filed against uniQure N.V. alleging false and misleading statements regarding its business and operations [1] - The lawsuit claims that the design of uniQure's Pivotal Study was not fully approved by the FDA and that the company downplayed the likelihood of delays in its Biologics License Application timeline [1] - The lawsuit specifically addresses the comparison of Pivotal Study results to the ENROLL-HD external historical data set [1] Group 2 - Shareholders who purchased uniQure shares between September 24, 2025, and October 31, 2025, and experienced significant losses are encouraged to discuss their legal rights [2] - The deadline to request to be appointed lead plaintiff in the case is April 13, 2026 [3] - Holzer & Holzer, LLC is a law firm specializing in shareholder class action and derivative litigation, having recovered hundreds of millions of dollars for shareholders [3]